tradingkey.logo
tradingkey.logo
Search

Hemab Therapeutics Holdings Ord Shs (Proposed)

COAG
Add to Watchlist
32.370USD
+4.650+16.77%
Close 06/26, 16:00ETQuotes delayed by 15 min
1.43BMarket Cap
--P/E TTM
You can check out the annual or quarterly balance sheets of Hemab Therapeutics Holdings Ord Shs (Proposed) here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Total equity
Cash, cash equivalents and short-term investments
--163.53M
- Cash and cash equivalents
--49.86M
-Short-term investments
--113.67M
Receivables
--1.43M
-Other receivables
--1.43M
Prepaid expenses
--4.47M
Total current assets
--169.43M
Non-current assets
Net Fixed Assets
--1.59M
-Fixed Assets
--2.38M
-Accumulated depreciation
--796.00K
Other non-current assets
--4.24M
Total non-current assets
--5.83M
Total assets
--175.26M
Liabilities
Current liabilities
-Other payables
--2.66M
Accrued expenses
--4.30M
Other current liabilities
--2.66M
Total current liabilities
--13.19M
Non-current liabilities
Long-term debt and lease liabilities
--519.00K
-Long-term lease liabilities
--519.00K
Total non-current liabilities
--519.00K
Total liabilities
--13.71M
Shareholders' equity
Common equity
--6.37M
Preferred equity
--291.40M
Retained earnings
---204.54M
Capital reserves
--6.37M
Gains losses not affecting retained earnings
---439.00K
Total equity
--161.55M
Currency unit
USD
Audit opinions
--

FAQs

What is the balance sheet?

It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.
KeyAI